Divestiture

A multimillion-dollar Morristown property sale reveals the forces shaping East Tennessee: savvy developers, strategic legal counsel, and booming secondary markets.

OFAC's new license allows U.S. firms to trade Venezuelan gold, but a history of expropriation and illicit mining presents a high-stakes gamble for companies.

The global firm secured over $18M in contracts for LA's Convention Center modernization and key stormwater programs, shaping the city's economic and eco-future.

Tsakos Energy Navigation reports a 200% Q4 income jump, capitalizing on high tanker rates while investing in a new fleet of LNG and VLCC vessels.

AIRO Group will present its future vision at a major tech conference, facing investor scrutiny amid ambitious growth plans and recent financial hurdles.

Propelled by its teen-focused Journeys brand, the footwear retailer posted strong profits, navigating mixed results in other divisions and setting a path for 2027.

After a strategic overhaul, Aegis Brands reports a stunning Q4 profit, with its St. Louis chain's double-digit sales growth validating its new focused strategy.

As Galapagos pivots its strategy, it brings in a new HR chief to build the high-performing culture crucial for its next chapter of innovation.

Kura Oncology's new AML drug, KOMZIFTI, sees rapid market uptake, strong financials, and an ambitious plan to reshape targeted cancer therapy.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

A landmark ruling allows the state to investigate the Seattle Archdiocese's handling of child sex abuse, a move hailed as a victory for transparency.

Record crop insurance enrollment reveals a stark reality: farmers are spending billions to shield themselves from volatile weather and unpredictable markets.

With a tenfold increase in volunteer hours since 2021, energy giant Avangrid is redefining corporate citizenship, linking community service to its core strategy.

A new poll reveals overwhelming public opposition to a federal plan to stockpile glyphosate, fueled by billions in lawsuits and a retracted safety study.

With record 2025 revenue and a dominant hold on the gene therapy market, Cryoport's strategic investments pave a path toward profitability.

A new lawsuit claims unregulated betting machines turn stores into crime magnets, putting workers in danger. This follows a landmark $15.3M verdict.

BARR Certifications now offers a single, coordinated audit for security, privacy, and AI, helping businesses navigate a complex regulatory landscape.

Chicago attorney Eirene N. Salvi's Crain's honor highlights a career balancing record-setting verdicts with profound community service and judicial reform.

Texas's largest housing authority marks 10 years of flawless financial audits while launching major housing projects and navigating community challenges.

Lantheus gains FDA tentative approval for a LUTATHERA rival, signaling new hope for rare cancer patients and a legal battle with Novartis over market access.